Literature DB >> 21229224

Temperature-sensitive bacterial pathogens generated by the substitution of essential genes from cold-loving bacteria: potential use as live vaccines.

Barry N Duplantis1, Catherine M Bosio, Francis E Nano.   

Abstract

Temperature-sensitive (TS) viruses have been used for decades as vaccines capable of limited replication in their hosts. Although attenuated bacteria, such as the Bacille Calmette-Guérin anti-tuberculosis vaccine, have been used for almost a century, it is only recently that there has been progress in using TS bacterial strains as live vaccines. Decades of work on essential bacterial genes and the recent explosion in the number of available bacterial genomic sequences set the groundwork for the identification of essential genes from diverse bacteria. This knowledge has allowed for the substitution of essential genes from cold-loving bacteria into the chromosomes of pathogenic bacteria. Many of these gene substitutions generated TS pathogenic bacterial strains, and some were demonstrated to provide protective immunity in mice. This work opens the possibility of engineering many pathogenic bacteria to create TS strains that can be used as vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21229224     DOI: 10.1007/s00109-010-0721-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   5.606


  48 in total

1.  Investigations towards an efficacious and safe strangles vaccine: submucosal vaccination with a live attenuated Streptococcus equi.

Authors:  A A Jacobs; D Goovaerts; P J Nuijten; R P Theelen; O M Hartford; T J Foster
Journal:  Vet Rec       Date:  2000-11-11       Impact factor: 2.695

2.  Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA.

Authors:  Y Ji; B Zhang; S F Van; P Warren; G Woodnutt; M K Burnham; M Rosenberg
Journal:  Science       Date:  2001-09-21       Impact factor: 47.728

3.  Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig.

Authors:  H T EIGELSBACH; C M DOWNS
Journal:  J Immunol       Date:  1961-10       Impact factor: 5.422

4.  Global transposon mutagenesis and essential gene analysis of Helicobacter pylori.

Authors:  Nina R Salama; Benjamin Shepherd; Stanley Falkow
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

Review 5.  Development and characterization of cold-adapted viruses for use as live virus vaccines.

Authors:  H F Maassab; D C DeBorde
Journal:  Vaccine       Date:  1985-12       Impact factor: 3.641

6.  Live attenuated versus inactivated influenza vaccine in infants and young children.

Authors:  Robert B Belshe; Kathryn M Edwards; Timo Vesikari; Steven V Black; Robert E Walker; Micki Hultquist; George Kemble; Edward M Connor
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

7.  Response of ewes to temperature-sensitive mutants of Chlamydia psittaci (var ovis) obtained by NTG mutagenesis.

Authors:  A Rodolakis; A Souriau
Journal:  Ann Rech Vet       Date:  1983

8.  Large-scale identification of essential Salmonella genes by trapping lethal insertions.

Authors:  Karin Knuth; Heide Niesalla; Christoph J Hueck; Thilo M Fuchs
Journal:  Mol Microbiol       Date:  2004-03       Impact factor: 3.501

9.  Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates.

Authors:  Michelle H Larsen; Karolin Biermann; Bing Chen; Tsungda Hsu; Vasan K Sambandamurthy; Andrew A Lackner; Pyone Pyone Aye; Peter Didier; Dan Huang; Linyun Shao; Huiyong Wei; Norman L Letvin; Richard Frothingham; Barton F Haynes; Zheng W Chen; William R Jacobs
Journal:  Vaccine       Date:  2009-06-02       Impact factor: 3.641

10.  Immunity against tularemia: passive protection of mice by transfer of immune tissues.

Authors:  W P ALLEN
Journal:  J Exp Med       Date:  1962-02-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Human body temperature and new approaches to constructing temperature-sensitive bacterial vaccines.

Authors:  Matthew D White; Catharine M Bosio; Barry N Duplantis; Francis E Nano
Journal:  Cell Mol Life Sci       Date:  2011-05-31       Impact factor: 9.261

2.  Evolutionarily conserved essential genes from arctic bacteria: a tool for vaccination.

Authors:  Mm Shanmugam; S Parasuraman
Journal:  J Young Pharm       Date:  2012-01

Review 3.  Materials and Devices for Biodegradable and Soft Biomedical Electronics.

Authors:  Rongfeng Li; Liu Wang; Lan Yin
Journal:  Materials (Basel)       Date:  2018-10-26       Impact factor: 3.623

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.